A randomized clinical trial of passive immunotherapy with single-dose anti-Fel d1 monoclonal antibodies REGN 1908-1909 in cat-induced rhinoconjunctivitis: exploratory efficacy endpoints, safety, and-MedSci.cn

A randomized clinical trial of passive immunotherapy with single-dose anti-Fel d1 monoclonal antibodies REGN 1908-1909 in cat-induced rhinoconjunctivitis: exploratory efficacy endpoints, safety, and

Durham, S; Schwabe, C; Robson, R; Emanuelsson, CA; Shamji, M; Singh, D; Mant, T; Clarke, G; Zhong, S; Kamal, M; Newell, D; Stahl, N; Yancopoulos, GD; Kostic, A

ALLERGY, 2017; 72 ( ): 64

科室
- - 订阅+
  - 更多科室
工具
服务